☰

Cathy Davies - Publications

Affiliations: 
Department of Psychosis Studies King's College London, London, UK 
Area:
Psychosis, MRI, Memory
Website:
https://kclpure.kcl.ac.uk/portal/cathy.davies.html
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Davies C, Martins D, Dipasquale O, McCutcheon RA, De Micheli A, Ramella-Cravaro V, Provenzani U, Rutigliano G, Cappucciati M, Oliver D, Williams S, Zelaya F, Allen P, Murguia S, Taylor D, et al. Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin. Molecular Psychiatry. PMID 38243074 DOI: 10.1038/s41380-024-02406-x  0.544
2023 Davies C, Bossong MG, Martins D, Wilson R, Appiah-Kusi E, Blest-Hopley G, Zelaya F, Allen P, Brammer M, Perez J, McGuire P, Bhattacharyya S. Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol. Psychological Medicine. 1-11. PMID 37845827 DOI: 10.1017/S0033291723002775  0.466
2023 Oliver D, Davies C, Zelaya F, Selvaggi P, De Micheli A, Catalan A, Baldwin H, Arribas M, Modinos G, Crossley NA, Allen P, Egerton A, Jauhar S, Howes OD, McGuire P, et al. Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling study. Frontiers in Psychiatry. 14: 1092213. PMID 36970257 DOI: 10.3389/fpsyt.2023.1092213  0.62
2022 Gunasekera B, Davies C, Blest-Hopley G, Veronese M, Ramsey NF, Bossong MG, Radua J, Bhattacharyya S. Task-independent acute effects of delta-9-tetrahydrocannabinol on human brain function and its relationship with cannabinoid receptor gene expression: A neuroimaging meta-regression analysis. Neuroscience and Biobehavioral Reviews. 140: 104801. PMID 35914625 DOI: 10.1016/j.neubiorev.2022.104801  0.407
2021 Fusar-Poli P, Radua J, Davies C, Jauhar S. Overoptimistic Literature and Methodological Biases Favoring Cognitive Behavioral Therapy for the Prevention of Psychosis. Schizophrenia Bulletin. PMID 34757422 DOI: 10.1093/schbul/sbab129  0.521
2021 Davies C, Appiah-Kusi E, Wilson R, Blest-Hopley G, Bossong MG, Valmaggia L, Brammer M, Perez J, Allen P, Murray RM, McGuire P, Bhattacharyya S. Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report. European Archives of Psychiatry and Clinical Neuroscience. PMID 34480630 DOI: 10.1007/s00406-021-01318-z  0.407
2021 de Pablo GS, Davies C, de Diego H, Solmi M, Shin JI, Carvalho AF, Radua J, Fusar-Poli P. Transition to psychosis in randomised clinical trials of individuals at clinical high risk of psychosis compared to observational cohorts: a systematic review and meta-analysis. European Psychiatry : the Journal of the Association of European Psychiatrists. 1-22. PMID 34315555 DOI: 10.1192/j.eurpsy.2021.2222  0.633
2020 Davies C, Wilson R, Appiah-Kusi E, Blest-Hopley G, Brammer M, Perez J, Murray RM, Allen P, Bossong MG, McGuire P, Bhattacharyya S. A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis. Translational Psychiatry. 10: 311. PMID 32921794 DOI: 10.1038/S41398-020-0862-2  0.415
2020 Fusar-Poli P, Radua J, McKenna PJ, Laws K, Davies C, Jauhar S. Methodological Biases in CBT Trial-Commentary: Modular Cognitive-Behavioral Therapy for Affective Symptoms in Young Individuals at Ultra-High Risk of First Episode of Psychosis: Randomized Controlled Trial. Frontiers in Psychiatry. 11: 394. PMID 32848896 DOI: 10.3389/Fpsyt.2020.00394  0.611
2020 Martins D, Davies C, De Micheli A, Oliver D, Krawczun-Rygmaczewska A, Fusar-Poli P, Paloyelis Y. Intranasal oxytocin increases heart-rate variability in men at clinical high risk for psychosis: a proof-of-concept study. Translational Psychiatry. 10: 227. PMID 32655132 DOI: 10.1038/S41398-020-00890-7  0.479
2020 Schmidt A, Davies C, Paloyelis Y, Meyer N, De Micheli A, Ramella-Cravaro V, Provenzani U, Aoki Y, Rutigliano G, Cappucciati M, Oliver D, Murguia S, Zelaya F, Allen P, Shergill S, et al. Acute oxytocin effects in inferring others' beliefs and social emotions in people at clinical high risk for psychosis. Translational Psychiatry. 10: 203. PMID 32572020 DOI: 10.1038/S41398-020-00885-4  0.517
2020 Radua J, Davies C, Fusar-Poli P. Evaluation of variability in individual response to treatments in the clinical high-risk state for psychosis: A meta-analysis. Schizophrenia Research. PMID 32467067 DOI: 10.1016/J.Schres.2020.05.010  0.655
2020 Davies C, Segre G, Estradé A, Radua J, De Micheli A, Provenzani U, Oliver D, Salazar de Pablo G, Ramella-Cravaro V, Besozzi M, Dazzan P, Miele M, Caputo G, Spallarossa C, Crossland G, et al. Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis. The Lancet. Psychiatry. PMID 32220288 DOI: 10.1016/S2215-0366(20)30057-2  0.657
2020 Davies C, Wilson R, Appiah-Kusi E, Brammer M, Perez J, Murray R, Allen P, Bossong M, McGuire P, Bhattacharyya S. T145. EFFECTS OF CANNABIDIOL ON EMOTION PROCESSING IN PSYCHOSIS RISK: AN FMRI INVESTIGATION Schizophrenia Bulletin. 46: S286-S286. DOI: 10.1093/Schbul/Sbaa029.705  0.4
2020 Schmidt A, Davies C, Paloyelis Y, Rutigliano G, Cappucciati M, De Micheli A, Ramella-Cravaro V, Provenzani U, Scutt E, Oliver D, Murguia S, Zelaya F, Allen P, Shergill S, Morrison P, et al. T139. OXYTOCIN ENHANCES NEURAL EFFICIENCY IN INFERRING OTHERS’ SOCIAL EMOTIONS IN PEOPLE AT CLINICAL HIGH RISK FOR PSYCHOSIS Schizophrenia Bulletin. 46: S283-S284. DOI: 10.1093/Schbul/Sbaa029.699  0.525
2019 Fusar-Poli P, Davies C, Solmi M, Brondino N, De Micheli A, Kotlicka-Antczak M, Shin JI, Radua J. Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence). Frontiers in Psychiatry. 10: 764. PMID 31920732 DOI: 10.3389/Fpsyt.2019.00764  0.662
2019 Oliver D, Reilly TJ, Baccaredda Boy O, Petros N, Davies C, Borgwardt S, McGuire P, Fusar-Poli P. What Causes the Onset of Psychosis in Individuals at Clinical High Risk? A Meta-analysis of Risk and Protective Factors. Schizophrenia Bulletin. PMID 31219164 DOI: 10.1093/Schbul/Sbz039  0.623
2019 Fusar-Poli P, Davies C, Rutigliano G, Stahl D, Bonoldi I, McGuire P. Transdiagnostic Individualized Clinically Based Risk Calculator for the Detection of Individuals at Risk and the Prediction of Psychosis: Model Refinement Including Nonlinear Effects of Age. Frontiers in Psychiatry. 10: 313. PMID 31143134 DOI: 10.3389/Fpsyt.2019.00313  0.616
2019 Fusar-Poli P, Solmi M, Brondino N, Davies C, Chae C, Politi P, Borgwardt S, Lawrie SM, Parnas J, McGuire P. Transdiagnostic psychiatry: a systematic review. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 18: 192-207. PMID 31059629 DOI: 10.1002/Wps.20631  0.542
2019 Davies C, Rutigliano G, De Micheli A, Stone JM, Ramella-Cravaro V, Provenzani U, Cappucciati M, Scutt E, Paloyelis Y, Oliver D, Murguia S, Zelaya F, Allen P, Shergill S, Morrison P, et al. Neurochemical effects of oxytocin in people at clinical high risk for psychosis. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 30928180 DOI: 10.1016/J.Euroneuro.2019.03.008  0.56
2019 Minichino A, Rutigliano G, Merlino S, Davies C, Oliver D, De Micheli A, Patel R, McGuire P, Fusar-Poli P. Unmet needs in patients with brief psychotic disorders: Too ill for clinical high risk services and not ill enough for first episode services. European Psychiatry : the Journal of the Association of European Psychiatrists. 57: 26-32. PMID 30658277 DOI: 10.1016/J.Eurpsy.2018.12.006  0.626
2019 Davies C, Paloyelis Y, Rutigliano G, Cappucciati M, De Micheli A, Ramella-Cravaro V, Provenzani U, Antoniades M, Modinos G, Oliver D, Stahl D, Murguia S, Zelaya F, Allen P, Shergill S, et al. Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30626906 DOI: 10.1038/S41386-018-0311-6  0.571
2019 Davies C, Rutigliano G, Micheli AD, Stone JM, Ramella-Cravaro V, Provenzani U, Cappucciati M, McGuire P, Fusar-Poli P. F94. Effects Of Oxytocin On Neurochemical Metabolites In Psychosis Risk Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz018.506  0.552
2018 Fusar-Poli P, Davies C, Bonoldi I. A Case of a College Student Presenting With Mild Mental Health Problems. Jama Psychiatry. PMID 30347005 DOI: 10.1001/Jamapsychiatry.2018.2486  0.328
2018 Davies C, Radua J, Cipriani A, Stahl D, Provenzani U, McGuire P, Fusar-Poli P. Efficacy and Acceptability of Interventions for Attenuated Positive Psychotic Symptoms in Individuals at Clinical High Risk of Psychosis: A Network Meta-Analysis. Frontiers in Psychiatry. 9: 187. PMID 29946270 DOI: 10.3389/Fpsyt.2018.00187  0.668
2018 Fusar-Poli P, Werbeloff N, Rutigliano G, Oliver D, Davies C, Stahl D, McGuire P, Osborn D. Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk and the Prediction of Psychosis: Second Replication in an Independent National Health Service Trust. Schizophrenia Bulletin. PMID 29897527 DOI: 10.1093/Schbul/Sby070  0.616
2018 Davies C, Cipriani A, Ioannidis JPA, Radua J, Stahl D, Provenzani U, McGuire P, Fusar-Poli P. Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 17: 196-209. PMID 29856551 DOI: 10.1002/Wps.20526  0.666
2018 Rutigliano G, Merlino S, Minichino A, Patel R, Davies C, Oliver D, De Micheli A, McGuire P, Fusar-Poli P. Long term outcomes of acute and transient psychotic disorders: The missed opportunity of preventive interventions. European Psychiatry : the Journal of the Association of European Psychiatrists. 52: 126-133. PMID 29787962 DOI: 10.1016/J.Eurpsy.2018.05.004  0.551
2018 Oliver D, Davies C, Crossland G, Lim S, Gifford G, McGuire P, Fusar-Poli P. Can We Reduce the Duration of Untreated Psychosis? A Systematic Review and Meta-Analysis of Controlled Interventional Studies. Schizophrenia Bulletin. PMID 29373755 DOI: 10.1093/Schbul/Sbx166  0.563
2018 Radua J, Ramella-Cravaro V, Ioannidis JPA, Reichenberg A, Phiphopthatsanee N, Amir T, Yenn Thoo H, Oliver D, Davies C, Morgan C, McGuire P, Murray RM, Fusar-Poli P. What causes psychosis? An umbrella review of risk and protective factors. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 17: 49-66. PMID 29352556 DOI: 10.1002/Wps.20490  0.675
2018 Davies C, Rutigliano G, Cappucciati M, De Micheli A, Ramella-Cravaro V, Provenzani U, Schmidt A, Paloyelis Y, McGuire P, Fusar-poli P. S149. EFFECTS OF INTRANASAL OXYTOCIN ON RESTING CEREBRAL BLOOD FLOW IN PEOPLE AT ULTRA-HIGH RISK FOR PSYCHOSIS Schizophrenia Bulletin. 44: S383-S383. DOI: 10.1093/Schbul/Sby018.936  0.539
2018 Oliver D, Davies C, Crossland G, Lim S, Gifford G, McGuire P, Fusar-Poli P. F256. CAN WE REDUCE THE DURATION OF UNTREATED PSYCHOSIS? Schizophrenia Bulletin. 44: S323-S323. DOI: 10.1093/Schbul/Sby017.787  0.459
2018 Minichino A, Rutigliano G, Merlino S, Davies C, Oliver D, De Micheli A, McGuire P, Fusar-Poli P. T122. UNMET NEEDS IN PATIENTS WITH ACUTE TRANSIENT PSYCHOTIC DISORDERS (ATPD): ANALYSIS OF PATHWAYS TO CARE: AN 8 YEARS FOLLOW-UP STUDY Schizophrenia Bulletin. 44: S162-S163. DOI: 10.1093/Schbul/Sby016.398  0.481
2018 Fusar-poli P, Rutigliano G, Stahl D, Davies C, Bonoldi I, Reilly T, McGuire P. 34.2 IMPROVING THE DETECTION OF INDIVIDUALS AT RISK OF PSYCHOSIS IN SECONDARY MENTAL HEALTH CARE Schizophrenia Bulletin. 44: S56-S57. DOI: 10.1093/Schbul/Sby014.143  0.549
2017 Fusar-Poli P, Palombini E, Davies C, Oliver D, Bonoldi I, Ramella-Cravaro V, McGuire P. Why transition risk to psychosis is not declining at the OASIS ultra high risk service: The hidden role of stable pretest risk enrichment. Schizophrenia Research. PMID 28734908 DOI: 10.1016/J.Schres.2017.06.015  0.604
2017 Murray RM, Englund A, Abi-Dargham A, Lewis D, Di Forti M, Davies C, Sherif M, McGuire P, D'Souza C. Cannabis-associated psychosis: Neural substrate and clinical impact. Neuropharmacology. PMID 28634109 DOI: 10.1016/J.Neuropharm.2017.06.018  0.456
2017 Fusar-Poli P, De Micheli A, Cappucciati M, Rutigliano G, Davies C, Ramella-Cravaro V, Oliver D, Bonoldi I, Rocchetti M, Gavaghan L, Patel R, McGuire P. Diagnostic and Prognostic Significance of DSM-5 Attenuated Psychosis Syndrome in Services for Individuals at Ultra High Risk for Psychosis. Schizophrenia Bulletin. PMID 28521060 DOI: 10.1093/Schbul/Sbx055  0.611
2017 Fusar-Poli P, Rutigliano G, Stahl D, Davies C, Bonoldi I, Reilly T, McGuire P. Development and Validation of a Clinically Based Risk Calculator for the Transdiagnostic Prediction of Psychosis. Jama Psychiatry. PMID 28355424 DOI: 10.1001/Jamapsychiatry.2017.0284  0.588
2016 Fusar-Poli P, Rutigliano G, Stahl D, Davies C, De Micheli A, Ramella-Cravaro V, Bonoldi I, McGuire P. Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders. European Psychiatry : the Journal of the Association of European Psychiatrists. 42: 49-54. PMID 28212505 DOI: 10.1016/J.Eurpsy.2016.11.010  0.552
Show low-probability matches.